ID: ALA3319577

Max Phase: Preclinical

Molecular Formula: C31H46N4O7

Molecular Weight: 586.73

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1ccc(C[C@H](NC(=O)[C@@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC2CCCCC2)C(=O)[C@@]2(C)CO2)cc1

Standard InChI:  InChI=1S/C31H46N4O7/c1-21(32-27(36)19-35-13-15-41-16-14-35)29(38)34-26(18-23-9-11-24(40-3)12-10-23)30(39)33-25(28(37)31(2)20-42-31)17-22-7-5-4-6-8-22/h9-12,21-22,25-26H,4-8,13-20H2,1-3H3,(H,32,36)(H,33,39)(H,34,38)/t21-,25+,26+,31-/m1/s1

Standard InChI Key:  UHNYITHLNFUAIN-ZMELPTPBSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 586.73

Molecular Weight (Monoisotopic): 586.3366

AlogP: 1.37

#Rotatable Bonds: 14

Polar Surface Area: 138.60

Molecular Species: NEUTRAL

HBA: 8

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 11

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 11.86

CX Basic pKa: 5.04

CX LogP: 2.09

CX LogD: 2.09

Aromatic Rings: 1

Heavy Atoms: 42

QED Weighted: 0.28

Np Likeness Score: -0.35

References

1. de Bruin G, Huber EM, Xin BT, van Rooden EJ, Al-Ayed K, Kim KB, Kisselev AF, Driessen C, van der Stelt M, van der Marel GA, Groll M, Overkleeft HS..  (2014)  Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes.,  57  (14): [PMID:25006746] [10.1021/jm500716s]

Source

Source(1):

• Scientific Literature